Finance

Lists
Why is 603351 up 2,02%?
Dive Deeper
603351:SHA
Nanjing Well Pharmaceutical Group Co Ltd
CNÂ¥26,83
+2,02%
(+0,53) 1D
16 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603351...
Open
CNÂ¥26,67
High
CNÂ¥28,39
Low
CNÂ¥26,41
Mkt. cap
3,63 mjd
Avg. vol.
1,42 m
Volume
2,95 m
Dividend
2,24%
Quarterly dividend
CNÂ¥0,15
Ex-dividend date
05 Jun. 2026
P/E ratio
23,45
52-wk high
CNÂ¥30,80
52-wk low
CNÂ¥21,90
EPS
CNÂ¥1,14
No. of employees
718
Open
CNÂ¥26,67
High
CNÂ¥28,39
Low
CNÂ¥26,41
Mkt. cap
3,63 mjd
Avg. vol.
1,42 m
Volume
2,95 m
Dividend
2,24%
Quarterly dividend
CNÂ¥0,15
Ex-dividend date
05 Jun. 2026
P/E ratio
23,45
52-wk high
CNÂ¥30,80
52-wk low
CNÂ¥21,90
EPS
CNÂ¥1,14
No. of employees
718
News stories
From web sources and news partners
About Nanjing Well Pharmaceutical Group Co Ltd
CEO-
Employees718
Founded18 Feb. 2000
Headquarters-
SectorCommodity chemical
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
344,52 m
316,80 m
356,30 m
383,29 m
Cost of goods sold
240,25 m
232,82 m
258,38 m
279,80 m
Cost of revenue
240,25 m
232,82 m
258,38 m
279,80 m
Research and development expenses
22,83 m
20,55 m
19,09 m
21,08 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33,00 m
25,44 m
27,73 m
33,67 m
Operating expense
54,62 m
47,14 m
48,21 m
55,06 m
Total operating expenses
294,87 m
279,96 m
306,58 m
334,86 m
Operating income
49,65 m
36,83 m
49,72 m
48,43 m
Other non operating income
-366,27 k
220,72 k
-2,06 m
1,94 m
EBT including unusual items
47,72 m
39,07 m
43,92 m
46,03 m
EBT excluding unusual items
46,87 m
33,62 m
43,93 m
45,70 m
Income tax expense
7,29 m
1,82 m
7,07 m
7,36 m
Effective tax rate
15,27%
4,65%
16,11%
15,98%
Other operating expenses
-1,05 m
1,06 m
506,84 k
372,91 k
Net income
41,30 m
36,90 m
37,63 m
39,15 m
Net profit margin
11,99%
11,65%
10,56%
10,21%
Earnings per share
-
-
-
-
Interest and investment income
267,66 k
85,57 k
113,84 k
360,14 k
Interest expense
-2,41 m
-2,32 m
-3,85 m
-2,56 m
Net interest expenses
-2,14 m
-2,23 m
-3,73 m
-2,20 m
Depreciation and amortization charges
-
-
-
-
EBITDA
76,35 m
67,52 m
80,41 m
79,05 m
Gain or loss from assets sale
6,48 k
-16,25 k
-
-
AI content may include mistakes. Learn more
Google-programme